Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Eur J Dent Educ ; 14(2): 69-78, 2010 May.
Article in English | MEDLINE | ID: mdl-20522105

ABSTRACT

Communication is an essential element of the relationship between patient and dentist. Dental schools are required to ensure that undergraduates are adequately trained in communication skills yet little evidence exists to suggest what constitutes appropriate training and how competency can be assessed. This review aimed to explore the scope and quality of evidence relating to communication skills training for dental students. Eleven papers fitted the inclusion criteria. The review found extensive use amongst studies of didactic learning and clinical role-play using simulated patients. Reported assessment methods focus mainly on observer evaluation of student interactions at consultation. Patient involvement in training appears to be minimal. This review recommends that several areas of methodology be addressed in future studies, the scope of research extended to include intra-operative communication, and that the role of real patients in the development of communication skills be active rather than passive.


Subject(s)
Communication , Education, Dental/methods , Dentist-Patient Relations , Humans , Patient Simulation
2.
J Subst Abuse Treat ; 34(2): 192-201, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17512159

ABSTRACT

Waiting time is a contemporary reality of many drug abuse treatment programs, resulting in substantial problems for substance users and society. Individual and system factors that influence waiting time are diverse and may vary at different points in the treatment continuum. This study assessed waiting time preceding clinical assessment at a centralized intake unit and during the period after the assessment but before treatment entry. The present study included 577 substance abusers who were enrolled in a large clinical trial of two brief treatment interventions in a midsize metropolitan area in Ohio. Bivariate analyses identified individual and system factors that influenced preassessment and postassessment waiting time, as well as total wait to treatment services. Multivariate analyses demonstrated that longer wait time for an assessment is influenced by being court referred, less belief in having a substance abuse problem, and less desire for change. A shorter wait to actually enter treatment is predicted by having a case manager, being more ready for treatment, and having less severe employment and alcohol problems. The different influences present during the two waiting periods suggest that assessment and treatment programs need to implement system changes and entry enhancement interventions that are specific to the needs of substance abusers at each waiting period.


Subject(s)
Substance Abuse Treatment Centers/organization & administration , Substance-Related Disorders/rehabilitation , Waiting Lists , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Multivariate Analysis , Ohio , Patient Admission , Severity of Illness Index , Time Factors
3.
Eur J Cardiothorac Surg ; 14(1): 7-13; discussion 13-4, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9726608

ABSTRACT

OBJECTIVE: Modified Fontan procedures are now employed in several conditions unsuitable for bi-ventricular repair. Selection criteria have been relaxed. The procedure is palliative. Longterm outlook is unknown. This study evaluated factors associated with the development of a failing Fontan circulation and transplantation results. METHODS: Retrospective review of patients referred to a single centre for cardiac transplant assessment. RESULTS: Between 1985 and 1996, 46 of 448 cardiac transplants were performed for congenital heart disease. Nine of these were performed in patients with a failing Fontan circulation (four adults, five children). In six cases, the dominant ventricle had left ventricular (LV) morphology. Congenital anomalies included double outlet right ventricle (three cases), double inlet left ventricle (two cases), tricuspid atresia (two cases), and pulmonary atresia with intact ventricular septum (one case). Fontan procedures were performed in absence of sinus rhythm (four cases), atrio-ventricular (AV) valve regurgitation (two cases), aortic regurgitation and systolic LV dysfunction (one case), elevated mean pulmonary artery pressure (one case), and older age (>7 years, eight cases). Three patients required early re-operation and two needed permanent pacing. Subsequent deterioration associated with loss of sinus rhythm (four cases) and progressive AV valve regurgitation (seven cases) led to transplant assessment (at < 1 year, five cases; at 2-12 years, four cases). All patients were listed for transplantation. Three patients required intravenous inotropic support and three patients with lymphocytotoxic antibodies needed prospective crossmatching. Donor cardiectomy was modified to facilitate implantation. The recipient operation involved pulmonary artery reconstruction (using pericardium), modified atrial and direct caval anastomoses. Three patients died within 24 h of surgery (two graft failures, one haemorrhage). In operative survivors (n = 6), intensive care stay was 3-16 days, and hospital stay ranged from 14 to 32 days. There have been no subsequent deaths (follow up, 0.5-4.7 years). CONCLUSION: In high-risk Fontan candidates, transplantation may be preferable at the outset. Previous surgery, lymphocytotoxic antibodies, indeterminate pulmonary vascular resistance, emergency status, sub-optimal donor selection, and perioperative bleeding contribute to peri-operative mortality. In survivors, the outcome remains very encouraging.


Subject(s)
Fontan Procedure , Heart Defects, Congenital/surgery , Heart Transplantation , Antilymphocyte Serum , Cardiomyopathies/surgery , Child, Preschool , Heart Defects, Congenital/physiopathology , Heart Transplantation/mortality , Hospital Mortality , Humans , Infant , Myocardial Ischemia/surgery , Pulmonary Artery/physiopathology , Retrospective Studies , Survival Analysis , Treatment Failure , Vascular Resistance
4.
Arch Dis Child ; 79(6): 510-3, 1998 Dec.
Article in English | MEDLINE | ID: mdl-10210997

ABSTRACT

BACKGROUND: Thoracentesis and antibiotics remain the cornerstones of treatment in stage I empyema. The management of disease progression or late presentation is controversial. Open thoracotomy and decortication is perceived to be synonymous with protracted recovery and prolonged hospitalisation. Advocates of thoracoscopic adhesiolysis cite earlier chest drain removal and hospital discharge. This paper challenges traditional prejudice towards open surgery. METHODS: A five year audit of empyema cases referred to a regional cardiothoracic surgical unit analysing previous clinical course, surgical management, and outcome. RESULTS: Between February 1992 and February 1997, the number of referrals to this centre increased dramatically. Twenty-two children were referred for surgery (15 boys, seven girls; age range, 0.5-16 years). Before referral, patients had been unwell for 6-50 days (median, 15), had been treated with several antibiotics, and had undergone chest ultrasound (15 patients), computed tomography (five patients), pleural aspiration attempts (13 patients), and intercostal drainage (seven patients). The organism responsible was identified in only two cases (Streptococcus pneumoniae). Three patients had intraparenchymal abscess formation. Eighteen patients underwent open thoracotomy and decortication. Drain removal was performed on the first or second day. Fever resolved within 48 hours. Median hospital stay was four days. All patients had complete clinical and radiological resolution. CONCLUSIONS: Treatment must be tailored to the disease stage. In stage II and III diseases, open decortication followed by early drain removal results in rapid symptomatic recovery, early hospital discharge, and complete resolution. In the early fibrinopurulent phase, alternative strategies should be considered. However, even in ideal cases, neither fibrinolysis nor thoracoscopic adhesiolysis can achieve more rapid resolution at lower risk.


Subject(s)
Empyema, Pleural/surgery , Lung/surgery , Medical Audit , Thoracotomy , Adolescent , Child , Child, Preschool , Drainage , Empyema, Pleural/diagnostic imaging , Female , Humans , Infant , Lung/diagnostic imaging , Male , Radiography , Treatment Outcome
5.
Ann Thorac Surg ; 59(2): 393-7, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7847954

ABSTRACT

We recently have used retrograde cerebral perfusion via the superior vena cava in association with hypothermic circulatory arrest as an adjunct to cerebral protection during aortic arch operations. Between April 1993 and March 1994, 23 patients (14 male; 9 female; median age, 64 years; age range, 25 to 76 years; 14 emergency, 9 elective) underwent operation on the ascending aorta, aortic arch, or both for acute dissection (11) or aneurysm (12). Aortic root replacement was performed in 13 patients (7 with arch replacement), ascending aortic replacement in 7 (4 with arch replacement), isolated aortic arch replacement in 2, and repair of sinus of Valsalva aneurysm in 1. Coronary artery bypass grafting was performed in 4 patients. Hypothermic circulatory arrest (15 degrees C) and retrograde cerebral perfusion were implemented in all cases (median circulatory arrest time, 21 minutes; range, 13 to 51 minutes; median retrograde cerebral perfusion time, 20 minutes; range, 12 to 50 minutes). Three hospital deaths occurred (atheromatous embolic stroke, sepsis, rupture of infrarenal aortic aneurysm). The remaining patients had no neurologic damage (median intensive therapy unit stay, 1 day; range, 1 to 5 days). Retrograde cerebral perfusion is easy to establish and safe, and may improve brain protection during hypothermic circulatory arrest.


Subject(s)
Aorta/surgery , Cerebrovascular Circulation , Perfusion/methods , Adult , Aged , Cardiopulmonary Bypass , Elective Surgical Procedures , Emergencies , Female , Heart Arrest, Induced , Humans , Hypothermia, Induced , Male , Middle Aged
6.
Am J Cardiol ; 74(11): 1142-6, 1994 Dec 01.
Article in English | MEDLINE | ID: mdl-7977075

ABSTRACT

To assess the immediate effects of aortic valve replacement (AVR) for valvular aortic stenosis (AS) on left ventricular (LV) systolic and diastolic function and global hemodynamics, 17 patients with AS underwent transesophageal echocardiography combined with high-fidelity LV pressure recording and thermodilution cardiac output measurements before cardiopulmonary bypass and 0.5, 6, 12, and 20 hours after AVR. Compared with results before bypass, LV systolic function had already changed 30 minutes after AVR, and remained constant thereafter: peak LV systolic wall stress decreased (from 210 +/- 60 to 130 +/- 40 g.cm-2), peak rate of dimension shortening increased (from 7.3 +/- 2.2 to 9.7 +/- 2.1 cm.s-1), both p < 0.01. Peak segmental external power thus remained constant (16.6 +/- 6.7 vs 17.7 +/- 7.6 mW.cm-3); p = NS. Changes in LV diastolic function and global hemodynamics were delayed. The peak rate of ventricular pressure decrease, normalized to developed end-systolic pressure, increased (from 15 +/- 3.2 to 19 +/- 5.2 s-1) by 6 hours. The minimal ventricular pressure of early diastole decreased (from 8.9 +/- 4.9 to 4.3 +/- 3.7 mm Hg), the peak rate of dimension lengthening of early diastole increased (from 6.0 +/- 3.0 to 8.8 +/- 2.0 cm.s-1), and LV stroke volume index increased (from 24 +/- 7 to 31 +/- 6 ml.m-2) by 12 hours, all p < 0.01. LV incoordination, defined as the dimension changes during isovolumic periods, had also improved significantly at 20 hours. Heart rate and LV enddiastolic dimension did not change.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Aortic Valve Stenosis/physiopathology , Aortic Valve Stenosis/surgery , Heart Valve Prosthesis , Ventricular Function, Left/physiology , Adult , Aged , Aortic Valve Stenosis/diagnostic imaging , Diastole/physiology , Echocardiography, Transesophageal , Female , Hemodynamics/physiology , Humans , Male , Middle Aged , Systole/physiology , Time Factors
7.
Br Heart J ; 72(5): 428-35, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7818959

ABSTRACT

OBJECTIVES: To evaluate trends in referrals for emergency operations after percutaneous transluminal coronary angioplasty (PTCA) complications; to analyse morbidity and mortality and assess the influence of PTCA backup on elective surgery. DESIGN: A retrospective analysis of patients requiring emergency surgical revascularisation within 24 hours of percutaneous transluminal coronary angioplasty. PATIENTS: Between January 1980 and December 1990, 75 patients requiring emergency surgery within 24 hours of percutaneous transluminal coronary angioplasty. SETTING: A tertiary referral centre and postgraduate teaching hospital. RESULTS: 57 patients (76%) were men, the mean age was 55 (range 29-73) years, and 30 (40%) had had a previous myocardial infarction. Before PTCA, 68 (91%) had severe angina, 59 (79%) had multivessel disease, and six (8%) had a left ventricular ejection fraction of less than 40%. A mean of 2.1 grafts (range one to five) were performed; the internal mammary artery was used in only one patient. The operative mortality was 9% and inhospital mortality was 17%. There was a need for cardiac massage until bypass was established in 19 patients (25%): this was the most important outcome determinant (P = 0.0051) and was more common in those patients with multivessel disease (P = 0.0449) and in women (P = 0.0388). In 10 of the 19 cases a vacant operating theatre was unavailable, the operation being performed in the catheter laboratory or anaesthetic room. These 19 patients had an operative mortality of 32% and inhospital mortality of 47%, compared with 2% and 7% respectively for the 56 patients who awaited the next available operating theatre. Complications included myocardial infarction, 19 patients (25%); arrhythmias, 10 patients (3%); and gross neurological event, two patients (3%). The mean intensive care unit stay was 2.6 days (range 1 to 33 days) and the mean duration of hospital admission was 13 days (range 5-40 days). CONCLUSIONS: Patients undergoing emergency surgery after PTCA complications have a substantially increased inhospital mortality and morbidity. PTCA in this unit continues to require surgical cover. Delays in operating on stable patients in centres which operate a "next available theatre" backup policy may not differ from some units performing PTCA with offsite cover for PTCA complications. Particularly in the presence of multivessel disease, however, PTCA complications may be associated with the need for "crash" bypass and such patients are unlikely to survive hospital transfer. The proportion of patients requiring "crash" bypass has increased during the period reviewed because of the extent of disease in the emergency surgical group increased. These results indicate that surgery should not be denied to these patients.


Subject(s)
Angioplasty, Balloon, Coronary/adverse effects , Coronary Artery Bypass , Coronary Vessels/injuries , Adult , Aged , Angioplasty, Balloon, Coronary/mortality , Coronary Artery Bypass/mortality , Emergencies , Female , Humans , Incidence , Male , Middle Aged , Prevalence , Prognosis , Retrospective Studies , Sex Factors , Treatment Failure
8.
J Surg Res ; 56(3): 256-60, 1994 Mar.
Article in English | MEDLINE | ID: mdl-7511718

ABSTRACT

Taurolidine has potent antiendotoxin and antimicrobial effects in vitro. This study assessed the effect of taurolidine in a well-described model of acute pancreatitis. Ninety-five male Wistar rats (250 g) were studied. Pancreatitis was induced by intraductal injection of 50 microliters of a 4% sodium taurocholate solution at a pressure of 25 cm water. Animals were randomly allocated to 1 of 10 groups: 4 groups were used to characterize the model and there were 6 treatment groups. Taurolidine (100 mg/kg) or saline was administered intravenously at Time 1, 4 hr, or 4 and 24 hr following induction of pancreatitis. Serum amylase, endotoxin levels, and blood cultures were assessed at 4 and 24 hr. Survival was documented at 1 week. Serum amylase levels were elevated in animals in whom acute pancreatitis was induced; however, there was no difference in serum amylase between animals treated with taurolidine and those treated with saline. Positive blood cultures were more numerous in saline-treated groups. Treatment with taurolidine was associated with significantly (P < 0.01) lower endotoxin levels (14 +/- 8 pg/ml) compared with saline-treated animals (350 +/- 87 pg/ml). Taurolidine administration significantly improved survival compared with controls, when given at 4, 24, and 4/24 hr postinduction of pancreatitis (P < 0.05). Taurolidine was beneficial in this model of acute pancreatitis.


Subject(s)
Pancreatitis/drug therapy , Taurine/analogs & derivatives , Thiadiazines/therapeutic use , Acute Disease , Amylases/blood , Animals , Male , Rats , Rats, Wistar , Taurine/therapeutic use
9.
Ann Thorac Surg ; 53(4): 572-7, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1554263

ABSTRACT

Positron emission tomography has recently been used to evaluate ischemic heart disease through changes in myocardial blood flow and carbohydrate metabolism. Positron-emitting tracers were evaluated for their ability to detect acute allograft rejection after heterotopic cardiac transplantation in the rat. Sham-operated controls, nonrejecting isografts, and rejecting allografts were evaluated. Decay-corrected uptake of 13NH3 and 18F 2-fluoro 2-deoxyglucose (FDG) reflects blood flow and glucose flux, respectively. Histologic examination of rejecting allografts documented mild rejection at 4 days and severe acute rejection by 8 days. All isografts were free from rejection. Uptake of FDG is greater in rejecting allografts than in nonrejecting isografts during both severe rejection (2.4% +/- 0.8% versus 0.7% +/- 0.4%; p less than 0.02) and mild rejection (2.1% +/- 0.6% versus 0.4% +/- 0.1%; p less than 0.02). Uptake of NH3 in severely rejected grafts is reduced compared with nonrejecting grafts (0.6% +/- 0.3% versus 1.7% +/- 1.1%; p less than 0.02). There is no difference in NH3 uptake during mild rejection (1.8% +/- 0.7% versus 1.3% +/- 0.3%; p greater than 0.05). Uptake of FDG and NH3 in native hearts of animals from all experimental groups is not significantly different from that in sham-operated controls. Glucose may be a preferred metabolic substrate during rejection. Our data support a humoral mechanism for substrate preference during transplant rejection and a potential diagnostic role for positron emission tomography.


Subject(s)
Graft Rejection , Heart Transplantation/diagnostic imaging , Tomography, Emission-Computed , Ammonia/metabolism , Animals , Coronary Circulation , Deoxyglucose/analogs & derivatives , Deoxyglucose/metabolism , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Half-Life , Heart Transplantation/pathology , Heart Transplantation/physiology , Male , Myocardium/metabolism , Myocardium/pathology , Nitrogen Radioisotopes , Rats , Rats, Inbred Lew , Time Factors , Transplantation, Homologous , Transplantation, Isogeneic
10.
Am Surg ; 58(2): 100-3, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1550299

ABSTRACT

From January 1969 through December 1989, 63 patients had 69 operations for pulmonary metastases. Patients ranged in age from 1 to 75 years; there were 36 men and 27 women. Metastasectomy was accomplished through a thoracotomy incision in 59 cases (5 staged, bilateral), and median sternotomy was used in 10 instances. Wedge resection was performed in 54 patients, with segmentectomy in 2, lobectomy in 12, and pneumonectomy in 1. There were no operative deaths. Multiple metastases were present in 29 patients, and a single metastasis in 34. Follow-up ranges from 2 to 204 months (mean = 42 months). Thirty-eight patients remain alive; thirty are free of disease and eight have developed other metastases. Actuarial survival at 5, 10, and 15 years is 40 (CL [confidence limits] 49,31), 36 (CL 44,26), and 24 (CL 35,13) per cent, respectively. Mean actuarial survival is 84 months, and median survival is 58 months. There is no difference in survival whether metastases were single or multiple. Survival is significantly less in groups with primary sarcoma and melanoma (P = .012). While pulmonary metastases may be a manifestation of terminal disease, metastasectomy has an important role in the multidisciplinary management of selected patients when metastatic disease is confined to the lung. Prolonged survival may be achieved in many patients.


Subject(s)
Lung Neoplasms/secondary , Lung Neoplasms/surgery , Pneumonectomy/statistics & numerical data , Actuarial Analysis , Adolescent , Adult , Aged , Carcinoma/mortality , Carcinoma/secondary , Carcinoma/surgery , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Male , Melanoma/mortality , Melanoma/secondary , Melanoma/surgery , Middle Aged , Neoplasm Recurrence, Local , Pneumonectomy/mortality , Sarcoma/mortality , Sarcoma/secondary , Sarcoma/surgery , Sternum/surgery , Survival Rate , Tennessee/epidemiology , Thoracotomy
11.
Ann Thorac Surg ; 51(5): 717-21; discussion 721-2, 1991 May.
Article in English | MEDLINE | ID: mdl-1850976

ABSTRACT

Of 29 patients with inferior vena caval tumor thrombus, 14 with supradiaphragmatic extension were deemed suitable for operation. Patients (age, 7.5 to 70 years) had renal cell carcinoma (n = 8), Wilms' tumor (n = 2), transitional cell carcinoma (n = 1), and adrenal carcinoma (n = 3). Seven patients had stage III disease, and 7 patients had stage IV disease. Two patients (group A) had unresectable disease at exploratory celiotomy, 4 patients (group B) underwent tumor thrombectomy without cardiopulmonary bypass, and cardiopulmonary bypass was employed in 8 patients (group C). Three of 8 group C patients had Budd-Chiari syndrome at diagnosis. Cardiopulmonary bypass with moderate hypothermia, and inferior vena caval interruption (clip or filter), was employed in all patients. There were no perioperative deaths. Transient neurological impairment was observed postoperatively in 2 patients. Coagulopathy developed in 1 patient who had hepatic encephalopathy and Budd-Chiari syndrome preoperatively and in another patient in whom protamine could not be administered. No patient had acute renal failure requiring hemodialysis. Median survival is 41 and 17 months in groups B and C, respectively. Some authors have advocated profound hypothermia and circulatory arrest in these patients. We find that satisfactory visualization and excision can be performed with cardiopulmonary bypass and moderate hypothermia, avoiding potential renal, hepatic, neurological, and septic complications associated with circulatory arrest.


Subject(s)
Cardiopulmonary Bypass , Kidney Neoplasms/complications , Thrombosis/surgery , Vena Cava, Inferior , Adolescent , Adult , Aged , Blood Transfusion , Carcinoma, Renal Cell/complications , Carcinoma, Renal Cell/mortality , Carcinoma, Renal Cell/pathology , Carcinoma, Renal Cell/secondary , Carcinoma, Transitional Cell/complications , Carcinoma, Transitional Cell/mortality , Carcinoma, Transitional Cell/pathology , Child , Female , Heart Arrest , Humans , Kidney Neoplasms/mortality , Kidney Neoplasms/pathology , Length of Stay , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm Staging , Postoperative Complications , Recurrence , Survival Rate , Thrombosis/etiology , Thrombosis/mortality , Wilms Tumor/complications , Wilms Tumor/mortality
12.
J Heart Transplant ; 9(3 Pt 2): 297-300, 1990.
Article in English | MEDLINE | ID: mdl-2113092

ABSTRACT

Polyclonal antilymphocytic preparations, heterologous antibodies to human lymphoid cells, have been administered to heart transplant recipients prophylactically in the immediate perioperative period to avert rejection. The current status of the three classes of polyclonal preparations (antilymphoblast globulins, antithymocyte globulins, and antithymocyte sera) and their clinical role for prophylaxis in heart transplantation are summarized.


Subject(s)
Antilymphocyte Serum/therapeutic use , Graft Rejection , Heart Transplantation , Immunosuppression Therapy , Adult , Animals , Antibodies, Monoclonal/therapeutic use , Female , Horses , Humans , Male , Muromonab-CD3 , Rabbits
16.
J Am Dent Assoc ; 81(4): 823-7, 1970 Oct.
Article in English | MEDLINE | ID: mdl-4917112
19.
Natl Conf Dent Public Relat ; 2: 601-3 passim, 1966.
Article in English | MEDLINE | ID: mdl-4381439
SELECTION OF CITATIONS
SEARCH DETAIL
...